Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the
Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic …

Epidemiological and clinical data have clearly demonstrated that non-alcoholic
steatohepatitis (NASH) predisposes risk to the development of hepatocellular carcinoma …

The underlying mechanism and pathogenesis of NAFLD remain elusive despite ongoing
researches to make significant advances in the understanding of its natural history …

The ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active
contributor or an innocent bystander in the development of cardiovascular disease (CVD) …

In the Western world, nonalcoholic fatty liver disease (NAFLD) is considered as one of the
most significant liver diseases of the twenty-first century. Its development is certainly driven …

Objectives To analyze the mRNA expression of interleukin-6 (IL-6) and tumour necrosis
factor-alpha (TNF-α) in the liver and white adipose tissue samples of individuals with class III …

Non-alcoholic fatty liver disease (NAFLD) is the most predominant liver disease worldwide
and hepatic manifestation of the metabolic syndrome. Its histology spectrum ranges from …

Abstract The IL-6− 174G/C (rs1800795), TNF-α− 308G/A (rs1800629) and− 238 G/A
(rs361525) and SDF-1 801 G/A (rs1801157) are well characterized SNPs which have …

Liver cirrhosis (LC) is a chronic illness caused by inflammatory responses and progressive
fibrosis. Globally, the most common causes of chronic liver disease include persistent …